Clinical Trial

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Study acronym: Cares-1
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
CARES-1 is a randomised, open-label, phase II pharmacokinetic (PK) and safety study of ambulatory antibiotics for the treatment of neonates with "all-risk" asymptomatic congenital syphilis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-03; most recent amendment 2026-05-06.
Status change: Not Yet Recruiting → Recruiting 2026-05-06
Trial Details
NCT Number NCT06921213
Lead Sponsor London School of Hygiene and Tropical Medicine
Collaborators: University College Dublin, University of Stellenbosch, Malawi Liverpool Wellcome Programme, University of Sydney, Murdoch Childrens Research Institute, MRC CTU at UCL, PHPT/AMS Laboratory, Faculty of Associated Medical Sciences, Chiang Mai University
Conditions Syphilis, Congenital
Enrollment 90 participants
Start Date 2026-05-04
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11